GO:0015677 copper ion import: Pathway, Genes, Methods

Copper is an essential trace element that serves as a catalytic cofactor for a wide range of enzymes involved in respiration, antioxidant defense, neurotransmitter synthesis, and iron metabolism. Because free copper is redox-active and potentially toxic, cells have evolved sophisticated import systems to acquire copper from the environment and deliver it to specific intracellular targets without causing oxidative damage. The Gene Ontology term GO:0015677, copper ion import, captures the directed movement of copper ions into a cell or organelle, a process that is fundamental to copper homeostasis across all domains of life. Understanding the molecular mechanisms of copper import is critical for researchers studying metal homeostasis, infectious disease, cancer metabolism, and neurodegenerative disorders. In bacteria, copper import is mediated by diverse systems, including the yersiniabactin metallophore system in Escherichia coli, which enables copper acquisition under copper-limiting conditions. Pathogenic streptococci also rely on tightly regulated metal homeostasis mechanisms to import copper while avoiding toxicity. Recent studies have identified prokaryotic mechanosensitive channels and a redox- and proton-coupled inner membrane transporter that mediate copper influx into the bacterial cytoplasm, expanding the known repertoire of copper import machinery. In mammalian cells, intracellular copper transport involves a network of chaperones and transporters that ensure copper delivery to mitochondria, the secretory pathway, and other organelles. In plant chloroplasts, copper is delivered for thylakoid import via specific chaperones, a process observed by NMR. Dysregulation of copper import has been implicated in Alzheimer's disease, where copper homeostasis is perturbed, and in cancer, where copper-dependent cell death (cuproptosis) can be induced by compounds such as triptolide. This article provides a comprehensive overview of GO:0015677, covering its definition, biological significance, key genes, regulatory mechanisms, disease associations, and research methodologies, with a focus on CRISPR-based approaches for functional interrogation.

GO:0015677 copper ion import is defined as the directed movement of copper ions into a cell or organelle. This biological process encompasses the transport of copper ions (Cu+ or Cu2+) across membranes, from the extracellular environment into the cytoplasm, or from the cytoplasm into intracellular organelles such as mitochondria, chloroplasts, or the secretory pathway. The term is synonymous with copper ion uptake and is distinct from copper ion export or intracellular copper distribution, although these processes are functionally coupled to maintain copper homeostasis.

Copper ion import is essential for life because copper is a required cofactor for enzymes that perform critical metabolic functions, including cytochrome c oxidase in mitochondrial respiration, superoxide dismutase in antioxidant defense, and ceruloplasmin in iron metabolism. Defects in copper import lead to copper deficiency, which manifests as severe disorders such as Menkes disease, characterized by neurodegeneration, connective tissue abnormalities, and impaired growth. Conversely, excessive copper import can trigger cuproptosis, a form of regulated cell death driven by copper-induced lipoylated protein aggregation, which has emerged as a promising anticancer strategy. In bacterial pathogens, copper import systems are virulence factors that enable survival within the host, where copper is used as a weapon by the immune system. Understanding copper import mechanisms is therefore critical for developing therapies against infectious diseases, cancer, and neurodegenerative disorders.

The following genes and proteins are key players in copper ion import across different organisms, as supported by the verified literature.

Copper ion import is regulated at multiple levels to maintain copper homeostasis. In mammalian cells, the transcription factor SP1 controls the expression of CTR1, and copper deficiency increases CTR1 mRNA levels, while copper excess promotes CTR1 ubiquitination and degradation. In bacteria, copper-responsive regulators such as CueR sense intracellular copper and modulate the expression of copper import and efflux systems. The yersiniabactin system in Escherichia coli is regulated by both iron and copper availability, ensuring that copper import is activated under copper-limiting conditions. Additionally, post-translational modifications and protein-protein interactions regulate the activity of copper chaperones and transporters. In chloroplasts, copper delivery to the thylakoid is regulated by the availability of copper and the expression of chaperones, as observed by NMR.

Menkes disease is an X-linked disorder caused by mutations in ATP7A, a copper-transporting ATPase that functions downstream of copper import. Impaired copper import and distribution lead to copper deficiency in the brain and other tissues, resulting in neurodegeneration, connective tissue abnormalities, and early death. Studies in model systems have shown that copper import via CTR1 is essential for neuronal development and function, and its dysregulation is linked to neurodegenerative conditions. In Alzheimer's disease, copper homeostasis is perturbed, and copper import mechanisms may contribute to amyloid-beta aggregation and oxidative stress.

Cuproptosis is a recently described form of regulated cell death triggered by excessive intracellular copper, which leads to the aggregation of lipoylated proteins and loss of iron-sulfur cluster proteins. Triptolide, a natural compound, has been shown to induce cuproptosis in cervical cancer cells by disrupting copper homeostasis, suggesting that modulating copper import could be a therapeutic strategy. Cancer cells often have altered copper metabolism, with increased copper import to support proliferation and angiogenesis. Targeting copper import pathways, such as CTR1, may sensitize cancer cells to cuproptosis-inducing agents.

Pathogenic bacteria such as Escherichia coli and streptococci rely on copper import systems to acquire copper for essential enzymes and to resist host-imposed copper toxicity. The yersiniabactin metallophore system in E. coli is a virulence factor that enables copper acquisition during infection. In pathogenic streptococci, copper homeostasis systems are critical for survival in the host, and their disruption attenuates virulence. Understanding bacterial copper import mechanisms could lead to new antimicrobial strategies that target these systems.

RNA sequencing (RNA-seq) can be used to profile the expression of copper import genes under different copper conditions, revealing transcriptional regulation. In bacteria, RNA-seq has been used to identify copper-responsive regulons, such as those controlled by CueR. CRISPR-based screens, such as genome-wide knockout libraries, can identify genes required for copper import and copper-dependent growth, as demonstrated in cancer cell lines treated with cuproptosis inducers. These approaches enable unbiased discovery of novel copper import components.

Proteomics can identify proteins that interact with copper import machinery, such as chaperones and transporters. For example, affinity purification coupled with mass spectrometry has been used to map copper chaperone networks. Copper uptake assays using radioactive or fluorescent copper isotopes measure the rate of import in cells or organelles. In bacteria, the yersiniabactin system was characterized using biochemical assays to measure copper binding and transport. NMR spectroscopy has been used to observe copper delivery for thylakoid import in chloroplasts, providing structural insights.

Fluorescence microscopy with copper-responsive sensors or tagged copper transporters can visualize copper import dynamics in live cells. Tagged knock-in of CTR1 with a fluorescent protein allows tracking of its localization and trafficking. In bacteria, fluorescent copper sensors have been used to monitor cytoplasmic copper levels and import activity. Electron microscopy can reveal the ultrastructural localization of copper transporters in organelles.

CRISPR-Cas9 knockout, point mutation, knock-in, and overexpression models are powerful tools for dissecting copper import mechanisms. Knockout of CTR1 in cell lines abolishes copper uptake and leads to copper deficiency phenotypes. Point mutations in copper-binding domains of chaperones can disrupt copper delivery. Knock-in of disease-associated mutations in ATP7A or ATP7B recapitulates copper transport defects. Overexpression of bacterial copper importers can increase copper sensitivity and reveal transport kinetics. These models are essential for establishing causal relationships between genes and copper import.

Researchers studying copper ion import-related genes often need to determine whether a candidate gene is causally involved in copper uptake, how mutations affect transport activity, and whether modulating its expression alters disease phenotypes. EDITGENE provides comprehensive CRISPR-based services to address these questions with precision and reproducibility.

GO:0015677 copper ion import is a fundamental biological process that ensures the acquisition of copper for essential cellular functions while preventing toxicity. Research across bacteria, plants, and mammals has revealed diverse molecular mechanisms, from metallophore systems and mechanosensitive channels to chaperone-mediated delivery. Dysregulation of copper import is linked to severe human diseases, including Menkes disease, Alzheimer's disease, and cancer, making it a compelling target for therapeutic intervention. Advances in CRISPR-based models and high-throughput screening are accelerating the discovery of new copper import components and their roles in health and disease. EDITGENE's comprehensive services empower researchers to interrogate copper import genes with precision and translate findings into clinical applications.